Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Compugen Ltd (NASDAQ:CGEN)

3.90
Delayed Data
As of 11:44am ET
 -0.075 / -1.89%
Today’s Change
3.85
Today|||52-Week Range
7.57
-23.53%
Year-to-Date
No recent news for Compugen Ltd.

Today’s Trading

Previous close3.98
Today’s open3.90
Day’s range3.90 - 3.98
Volume11,874
Average volume (3 months)124,935
Market cap$203.2M
Dividend yield--
Data as of 11:44am ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-55.00%
Earnings growth (this year)-10.21%
Earnings growth (next 5 years)--
Revenue growth (last year)-92.33%
P/E ratioNM
Price/Sales364.28
Price/Book3.20

Competitors

 Today’s
change
Today’s
% change
ENZYEnzymotec Ltd-0.20-2.26%
FATEFate Therapeutics In...-0.10-2.03%
ASTAsterias Biotherapeu...-0.08-1.95%
NVAXNovavax Inc-0.01-1.24%
Data as of 12:09pm ET, 04/28/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$712.0K
Annual profit (last year)-$31.5M
Net profit margin-4,425.00%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Anat Cohen-Dayag
Chief Operating &
Financial Officer
Ari Krashin
Corporate headquarters
Holon, Tel Aviv

Forecasts